EBA
ARKG icon

Eagle Bay Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Eagle Bay Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$93K – 1076
2021
Q2 		$93K Buy
+1,000
New +$85K 0.07% 165

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Eagle Bay Advisors's ARKG Position: Q3 2021 in Review

Eagle Bay Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 1,000 shares — an estimated $93K sold.

Eagle Bay Advisors first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $93K in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Eagle Bay Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Eagle Bay Advisors sold 1,000 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $93K.
  • Eagle Bay Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
  • Eagle Bay Advisors's ARK Genomic Revolution ETF position peaked at $93K in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Eagle Bay Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.